Latest Breaking News On - Breakthrough devices program - Page 6 : comparemela.com

V-Wave Announces Late-Breaking Primary Results from Pivotal, Double-Blind, Randomized, Controlled RELIEVE-HF Trial of the Ventura® Interatrial Shunt Showing Reduced Clinical Events in Advanced Heart Failure Patients with Reduced Left Ventricular Ejection Fraction

V-Wave Announces Late-Breaking Primary Results from Pivotal, Double-Blind, Randomized, Controlled RELIEVE-HF Trial of the Ventura® Interatrial Shunt Showing Reduced Clinical Events in Advanced Heart Failure Patients with Reduced Left Ventricular Ejection Fraction
davisenterprise.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from davisenterprise.com Daily Mail and Mail on Sunday newspapers.

United statesElliot foxSource ltdDrug administrationDrug administration breakthrough devices programYork heart associationPrnewswire incWave incBreakthrough devices programNew york heart associationHeart failureInteratrial shuntV wave ventura interatrial shuntVentura shuntBreakthrough device designationLooking statement

V-Wave Announces Late-Breaking Primary Results from Pivotal, Double-Blind, Randomized, Controlled RELIEVE-HF Trial of the Ventura® Interatrial Shunt Showing Reduced Clinical Events in Advanced Heart Failure Patients with Reduced Left Ventricular Ejection Fraction

Results presented at ACC.24 showed that overall neutral results were due to directionally opposite effects in patients with reduced vs. preserved left ventricular ejection fraction

United statesElliot foxSource ltdDrug administration breakthrough devices programPrnewswire incYork heart associationWave incDrug administrationBreakthrough devices programNew york heart associationV wave ventura interatrial shunt system

V-Wave Announces Late-Breaking Primary Results from Pivotal, Double-Blind, Randomized, Controlled RELIEVE-HF Trial of the Ventura® Interatrial Shunt Showing Reduced Clinical Events in Advanced Heart Failure Patients with Reduced Left Ventricular Ejection Fraction

V-Wave Announces Late-Breaking Primary Results from Pivotal, Double-Blind, Randomized, Controlled RELIEVE-HF Trial of the Ventura® Interatrial Shunt Showing Reduced Clinical Events in Advanced Heart Failure Patients with Reduced Left Ventricular Ejection Fraction
bubblear.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bubblear.com Daily Mail and Mail on Sunday newspapers.

United statesElliot foxYork heart associationSource ltdDrug administrationDrug administration breakthrough devices programV wave incBreakthrough devices programNew york heart associationHeart failureInteratrial shuntV wave ventura interatrial shuntVentura shuntBreakthrough device designationLooking statementV wave ventura interatrial shunt system

V-Wave to Present Late-Breaking Data from Pivotal RELIEVE-HF Study at American College of Cardiology Annual Scientific Session and Expo

V-Wave announced it will present late-breaking data from its RELIEVE-HF pivotal trial at ACC24

New zealandNeal eiglerAmerican college of cardiologyDrug administration breakthrough devices programAmerican collegeAnnual scientific sessionV wave venturaInteratrial shuntPlacebo procedure controlled trialPrincipal results fromBreaking clinical trialsJoint american collegeCardiology late breaking clinical trialsDrug administrationBreakthrough devices program

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Evoque and Patisiran: A Tale of Two Regulatory Journeys
tctmd.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tctmd.com Daily Mail and Mail on Sunday newspapers.

United statesSymplicity spyral medtronicMitraclip abbottAngelmed guardian avertixEdwards lifesciencesAlnylam pharmaceuticalsDrug administrationBoston scientificUs congressBreakthrough devices programComplete response letterAngelmed guardianRecor medicalSymplicity spyral